Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Autolus Therapeutics plc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 65 | −5 |
| Shares | 107.5M | 1.73M | 106.1M | +324.6K (+0.3%) |
| Value | $204.2M | $3.29M | $195.1M | −$5.74M (−2.9%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Autolus Therapeutics plc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perpetual Ltd | 1,858,091 | $3.42M | 0.03% |
| UBS Oconnor LLC | 757,008 | $1.39M | 0.03% |
| Innovis Asset Management LLC | 126,106 | $232.0K | 0.09% |
| Jane Street Group, LLC | 95,876 | $176.4K | 0.00% |
| Boulder Hill Capital Management LP | 57,191 | $105.2K | 0.08% |
| Goldman Sachs Group Inc | 21,817 | $40.1K | 0.00% |
| Two Sigma Advisers, LP | 13,700 | $25.2K | 0.00% |
| Focused Wealth Management, Inc | 5,000 | $9.20K | 0.00% |
| Close Asset Management Ltd | 500 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Autolus Therapeutics plc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CVI Holdings, LLC | 1,237,511 | $2.35M |
| Capital World Investors | 625,000 | $1.19M |
| Sphera Funds Management Ltd. | 500,000 | $950.0K |
| Pentwater Capital Management LP | 400,000 | $760.0K |
| Caas Capital Management LP | 322,795 | $613.3K |
| Ergoteles LLC | 169,180 | $321.4K |
| Covalis Capital LLP | 67,767 | $128.8K |
| Alpine Global Management, LLC | 19,885 | $38.0K |
| SEI Investments Co | 15,040 | $28.6K |
| CI Private Wealth, LLC | 15,000 | $28.5K |
| Squarepoint Ops LLC | 10,407 | $19.8K |
| Group One Trading, L.P. | 2,700 | $5.13K |
| BNP Paribas Arbitrage, SA | 293 | $557 |
| Citigroup Inc | 92 | $175 |
Not filed for Q1 2023 yet (1)
Institutions that held Autolus Therapeutics plc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Pendal Group Limited | 1,733,391 | $3.29M |